LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.06 | 770.25 | 998 | 1218 | 0.8190 | 0.4792 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.06 | 770.25 | 1063 | 1218 | 0.8724 | 0.6271 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 12.28 | 770.25 | 1249 | 1358 | 0.9197 | 0.8054 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 12.28 | 770.25 | 1240 | 1358 | 0.9130 | 0.7895 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 12.28 | 770.25 | 1145 | 1358 | 0.8431 | 0.6234 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 12.28 | 770.25 | 1200 | 1358 | 0.8836 | 0.7192 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 14.50 | 770.25 | 1421 | 1497 | 0.9491 | 0.8939 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 14.50 | 770.25 | 1402 | 1497 | 0.9364 | 0.8675 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 14.50 | 770.25 | 1272 | 1497 | 0.8496 | 0.6873 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 14.50 | 770.25 | 1335 | 1497 | 0.8916 | 0.7745 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 16.73 | 770.25 | 1508 | 1664 | 0.9060 | 0.8300 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 16.73 | 770.25 | 1545 | 1664 | 0.9282 | 0.8704 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 16.73 | 770.25 | 1436 | 1664 | 0.8627 | 0.7512 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 16.73 | 770.25 | 1473 | 1664 | 0.8850 | 0.7918 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.95 | 770.25 | 1656 | 1832 | 0.9037 | 0.8444 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.95 | 770.25 | 1679 | 1832 | 0.9162 | 0.8649 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.95 | 770.25 | 1576 | 1832 | 0.8600 | 0.7728 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.95 | 770.25 | 1603 | 1832 | 0.8748 | 0.7970 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 21.17 | 770.25 | 1855 | 2008 | 0.9236 | 0.8883 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 21.17 | 770.25 | 1810 | 2008 | 0.9012 | 0.8551 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 21.17 | 770.25 | 1685 | 2008 | 0.8390 | 0.7615 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 21.17 | 770.25 | 1730 | 2008 | 0.8614 | 0.7954 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 23.39 | 770.25 | 2025 | 2244 | 0.9022 | 0.8710 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 23.39 | 770.25 | 2031 | 2244 | 0.9049 | 0.8746 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 23.39 | 770.25 | 1900 | 2244 | 0.8465 | 0.7953 | MN20160304_L02 | G14 |